Cargando…
A Randomized Placebo-Controlled Study of a Transcranial Photobiomodulation Helmet in Parkinson’s Disease: Post-Hoc Analysis of Motor Outcomes
Emerging evidence is increasingly supporting the use of transcranial photobiomodulation (tPBM) to improve symptoms of neurodegenerative diseases, including Parkinson’s disease (PD). The objective of this study was to analyse the safety and efficacy of tPBM for PD motor symptoms. The study was a trip...
Autores principales: | McGee, Claire, Liebert, Ann, Bicknell, Brian, Pang, Vincent, Isaac, Vivian, McLachlan, Craig S., Kiat, Hosen, Herkes, Geoffrey |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10146323/ https://www.ncbi.nlm.nih.gov/pubmed/37109183 http://dx.doi.org/10.3390/jcm12082846 |
Ejemplares similares
-
Protocol for randomized controlled trial to evaluate the safety and feasibility of a novel helmet to deliver transcranial light emitting diodes photobiomodulation therapy to patients with Parkinson’s disease
por: McGee, Claire, et al.
Publicado: (2022) -
Microbiome Changes in Humans with Parkinson’s Disease after Photobiomodulation Therapy: A Retrospective Study
por: Bicknell, Brian, et al.
Publicado: (2022) -
Photophysical Mechanisms of Photobiomodulation Therapy as Precision Medicine
por: Liebert, Ann, et al.
Publicado: (2023) -
Neurodegenerative and Neurodevelopmental Diseases and the Gut-Brain Axis: The Potential of Therapeutic Targeting of the Microbiome
por: Bicknell, Brian, et al.
Publicado: (2023) -
A Potential Role for Photobiomodulation Therapy in Disease Treatment and Prevention in the Era of COVID-19
por: Liebert, Ann, et al.
Publicado: (2020)